PBM Legislative Update: One Bill in the House, Three in the Senate | AMCP Nexus 2023
Melissa Andel, M.P.P., of CommonHealth Solutions LLC, thumbnailed the four pieces of legislation advancing through Congress that would tighten regulation and oversight of pharmacy benefit managers (PBMs).
In Washington and in healthcare, pharmacy benefit managers (PBMs) are in the legislative hotseat.
Today at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 meeting in Orlando, Melissa Andel, M.P.P.,summarized the various PBM bills under consideration and shared some insights into the legislative anbd political forces that are shaping their future and which provisions, if any, will survive and become law.
In a Zoom interview with Managed Healthcare Executive before the meeting, Andel, whose healthcare consultancy is called CommonHealth Solutions and who has worked in legislative affairs for AMCP, gave a brief overview of the PBM bills that have advanced in this session of Congress. A single bill has been put together in the House, according to Andel.
“On the Senate side, it’s a little bit more complicated,” said Andel, with separate bills having been voted out of the finance, health, education, labor and pensions, and commerce committees. The content of those bills is determined, in part, by the jurisdictions of those committees, Andel explained. For example, the Senate Finance Committee’s has jurisdiction over Medicare and Medicaid so its PBM legislation focuses on changing Medicare and Medicaid rules for PBMs and how drug expenditures are managed and covered.
Addressing the Challenges of AI is Imperative | AMCP Nexus 2024
October 22nd 2024There is a need for strict policies regarding the use of AI in the managed care space, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
October 21st 2024Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research.
Read More
How Technology Benefits Specialty Pharmacy | AMCP 2024
October 18th 2024Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at-risk patients, coordinates medication refills and more.
Read More
Cancer’s Reign Over the Drug Development Pipeline Continues| AMCP Nexus 2024
October 18th 2024The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several months and in early 2025, according to Kaelyn Boss, who gave an oncology drug pipeline talk at the 2024 AMCP Nexus meeting this week.
Read More
